VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NY...

• VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure.^[1]
• ATTR-CM is a debilitating and often fatal condition that leads to heart failure.^[2],[3]
• The availability of VYNDAMAX on the PBS provides subsidised access to a once-daily oral single-capsule treatment for ATTR-CM for adults with New York Heart Association (NYHA) Class I-II heart failure.^[1]

SYDNEY, May 4, 2024 /PRNewswire/ -- Pfizer Australia has welcomed the announcement that VYNDAMAX^® (tafamidis), which is approved in Australia for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM), will be listed on Australia's Pharmaceutical Benefits Scheme (PBS) for adults with New York Heart Association (NYHA) Class I-II heart failure from 1 May 2024.^[4]

ATTR-CM is an underdiagnosed disease affecting the heart,^[5] of which there are two types - hereditary ATTR-CM (hATTR) and wild-type ATTR-CM (wtATTR).^[2] hATTR-CM is caused by a gene mutation and can run in families. Symptoms can start as early as 20 years of age or as late as age 80.^[2],[3] wtATTR-CM is most common in men aged 65 or older but occurs rarely in women.^[2],[3] ATTR-CM occurs due to genetic mutation or aging where the transthyretin protein doesn't assemble normally, then clumps together into amyloid fibrils, and travels through the bloodstream where it is then deposited in the heart.^[2],[3]

People with ATTR-CM display symptoms of heart failure, with a thicker ventricular heart wall being a key feature in both types.^[3] A group of international experts suggested a way to identify the disease by looking out for certain symptoms and signs.^[3] These include a history of carpal tunnel syndrome in both hands and a slightly higher level of troponin, a protein found in the heart muscle cells and specific changes in heart function. Other symptoms affecting the eye, nerves, and stomach problems can also point to this condition, especially in hATTR.^[3]

"On average, people with ATTR-CM who do not receive treatment live for approximately three to five years after their diagnosis, so proactive identification and early intervention are critical to slow disease progression. The availability of VYNDAMAX on the PBS offers subsidised access to Australians living with ATTR-CM" said Professor Liza Thomas, Conjoint Professor at Sydney University and University of New South Wales and current Chair of the cardiac subcommittee of the Australian Amyloidosis Network.

"With the availability of this listing, specialists now have an option for patients based on factors such as disease stage, symptoms, and individual patient characteristics," Professor Thomas said.

The reimbursement of VYNDAMAX reflects Pfizer's ongoing effort to bring innovative treatments to Australian patients.

Anne Harris, Pfizer Australia and New Zealand Managing Director, said: "Pfizer's purpose is to deliver breakthrough medicines that change patients' lives.

"We thank the Australian Government for providing patients living with this rare, debilitating and often fatal disease with this treatment option. We are committed to working with healthcare professionals to raise awareness and enhance early detection and diagnosis of this condition," Ms Harris said.  

For more information about ATTR-CM visit the Australia Amyloidosis Network (AAN) website: https://aan.org.au/

To monitor outcomes of pregnant women exposed to VYNDAMAX, a Tafamidis Enhanced Surveillance for Pregnancy Outcomes (TESPO) program has been established. If a pregnancy occurs in a woman being treated with VYNDAMAX, medical or healthcare professionals are encouraged to report the pregnancy to Pfizer Australia.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reportingproblems.

See Consumer Medicine Information for details.

About Pfizer: Breakthroughs That Change Patients' Lives^TM

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. For more information, visit: www.pfizer.com.au.

References

Cision | Sat, May 04 2024 08:00 PM AEST

Investing.com-- The S&P 500 surged Friday as Apple led a surge in tech just as data showed jobs gains fell short of expectations in April, lifting hopes that the Federal Reserve could begin cutting in

Investing | Sat, May 04 2024 06:30 AM AEST

Investing.com-- The S&P 500 surged Friday as Apple led a surge in tech just as data showed jobs gains fell short of expectations in April, lifting hopes that the Federal Reserve could begin cutting interest rates sooner rather than later.

At 16:00 ET (20:00 GMT), Dow Jones Industrial Average rose 450 points, or 1.2%, S&P 500 rose 1.3%, and NASDAQ Composite climbed 2%.

Treasury yields slide after nonfarm payrolls shows slowing jobs growth

Treasury yields slipped on renewed hopes for rate cuts this year, after the data showed the U.S. economy added jobs at a slower rate in April, with only 175,000 jobs added last month, compared with a revised 315,000 in March.

The yield on the 10-year Treasury fell 6 basis points to 4.511%.

The unemployment rate also rose to 3.9% in April, climbing from 3.8% the prior month, but still the 27th consecutive month that the jobless rate has been below 4%. Crucially average hourly earnings growth slowed to 0.2% on the month.

"The data shows a labor market coming into better balance and we continue to expect three cuts this year," Morgan Stanley (NYSE:MS) said in a Friday note.

Apple leads tech higher on earnings, buyback

Apple (NASDAQ:AAPL) jumped 6%, leading the broader tech sector higher after Q2 results topped estimates and the iPhone maker unveiled a $110B stock buyback program as well as dividend hike.

iPhone sales fell just shy of analyst expectations, but the results were better than feared, particularly in China, in which slowing growth has been a key worry for investors.

Apple is expected to see the return of “renaissance of growth” as iPhone demand in China as well as services revenue are slowly starting to show signs of a turnaround, Wedbush Securities said in a Friday report. The tech giant’s move into AI, Wedbush adds, could drive the next supercycle.

Block slips despite Q1 beat; Amgen confident over weight-loss drug

Block (NYSE:SQ) fell more than 1% even as the payments firm posted first-quarter earnings that topped estimates, driven by boost in Bitcoin.

Amgen (NASDAQ:AMGN) stock surged nearly 12% after the biotechnology firm expressed confidence after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide.

Cybersecurity firm Cloudflare (NYSE:NET) slid 16% after weak guidance overshadowed strong quarterly earnings.

Crypto stocks mostly higher on Bitcoin rally, but Coinbase falters

This article first appeared in Investing.com

Australia Period Care Market Size, Share The period underwear segment is estimated to witness the fastest growth, registering a CAGR of 7.4% during the forecast period. The pure play online segment is...

EIN Presswire | Sat, May 04 2024 04:33 AM AEST

WILMINGTON, NEW CASTLE, DELAWARE 19801 USA, UNITED STATES, May 4, 2024 /EINPresswire.com/ -- According to a new report, According to a new report, Australia Period Care Market by Product Type, Distribution Channel: Opportunity Analysis and Industry Forecast, 2021-2030. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The Australia period care market was valued at $630.0 million in 2020, and is projected reach $1,028.7 million by 2030, registering a CAGR of 5.3% from 2021 to 2030.

Download Sample Report @https://www.alliedmarketresearch.com/request-sample/14685

Increase in focus on product innovations and surge in emphasis on tampons made of organic and biodegradable materials are the factors expected to fuel the growth of the period care market in Australia. The reusable period care products have gained traction in the past few years. There are many people who cannot afford the costs of buying menstruation care products regularly.

The period care market in Australia has experienced notable growth in recent years, driven by increasing awareness of feminine hygiene and greater availability of sanitary pads. Despite lingering social taboos surrounding menstrual hygiene in certain regions, government-led initiatives promoting personal hygiene have spurred demand for period care products nationwide. This heightened interest among women has also extended to alternative products such as panty liners and period underwear, reflecting a growing preference for innovative, reusable, and environmentally friendly options.

Concerns regarding the health and environmental impacts of traditional menstrual products have prompted a shift towards eco-friendly and biodegradable alternatives. Menstrual cups, reusable pads, and sanitary underwear have emerged as popular choices among women seeking sustainable and safe options. Furthermore, market growth is fueled by ongoing product innovation efforts by manufacturers, who continually strive to meet the evolving needs and preferences of consumers.

The adoption of reusable menstruation care products is on an increase owing to the rise in emphasis on the sustainable products. Most of the disposable period care products are made using plastic, which is non-biodegradable and they harm the environment. Disposable sanitary pads are one of the highest waste generators in Australia.

The Australia period care market is segmented on the basis of product type and distribution channel. By product type, the market is categorized into sanitary pads, tampons, panty liners & shields, period underwear, and menstrual cups. Sanitary pads are the most commonly used feminine hygiene products and are expected to grow at significant rate owing to increase in demand, rise in awareness, and increased government initiatives regarding menstruation care. By distribution channel, the market is divided into discount department store, department store, grocery store, pure play online, dollar stores, specialty/independent store, retail pharmacy, brick mortar online, and convenience store.

Browse Full Report @https://www.alliedmarketresearch.com/checkout-final/36407ca30cb6f7eed059322c0a44ec39

Sanitary pads, tampons, panty liners, menstrual cups, and period underwear are considered as the menstrual care or period care products. These products help absorb the menstrual fluid. Sanitary pads are the most commonly used menstrual care products among all types of period care products due to its higher penetration in Australia. Moreover, increase in number of working women in Australia has fuelled the growth of the market. Increased government initiatives to spread awareness regarding period care boosts the growth of the Australia period care market. The Sustainable Period Project is an initiative in Australia that helps in educating the Australian women regarding the reusable and sustainable period care options.

The key market players profiled in this report include Unicharm Corporation, Kimberly-Clark Corporation, Procter & Gamble Co., Edgewell Personal Care Company, Knicked, Wunderthings, Modibodi, Love Luna, Juju, and Bonds. The industry is robust in nature with the presence of several large players.

𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐞𝐫𝐢𝐨𝐝 𝐂𝐚𝐫𝐞 𝐢𝐧 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚:

𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲: The period care market in Australia has seen a surge in innovative products beyond traditional disposable pads and tampons. Menstrual cups, reusable cloth pads, period underwear, and organic disposable products have gained popularity, offering consumers a wider range of options to choose from based on their preferences and needs.

𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲: There's a growing emphasis on sustainability within the period care industry, with more consumers opting for eco-friendly and reusable alternatives to reduce environmental impact. This shift aligns with broader trends toward sustainability and conscious consumerism, driving demand for products that are not only effective but also environmentally responsible.

𝐀𝐝𝐯𝐨𝐜𝐚𝐜𝐲 𝐚𝐧𝐝 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬: Organizations and activists in Australia have been working tirelessly to raise awareness about menstrual health and advocate for menstrual equity. Initiatives such as campaigns to end period poverty, promote menstrual education in schools, and advocate for access to affordable and safe period products have gained momentum, contributing to a more informed and supportive environment for menstruators.

𝐏𝐨𝐥𝐢𝐜𝐲 𝐂𝐡𝐚𝐧𝐠𝐞𝐬: There have been efforts to address period poverty and improve access to period products through policy changes at various levels of government. Some Australian states have implemented initiatives to provide free menstrual products in schools, workplaces, and public facilities, aiming to ensure that menstruators have equitable access to essential period care resources.

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬 𝐚𝐧𝐝 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧: The proliferation of digital platforms and social media has facilitated greater access to menstrual health information and resources. Online platforms, apps, and social media campaigns play a crucial role in destigmatizing menstruation, providing educational content, and fostering supportive communities where individuals can share experiences and seek advice related to period care.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬:

○ The report provides an extensive analysis of the current & emerging trends and opportunities in the Australia period care market.
○ It provides detailed qualitative and quantitative analyses of current trends and future estimations, which help understand the prevailing market opportunities.
○ A comprehensive analysis of factors that drive and restrict the growth of the Australia period care market is highlighted in the study.
○ An extensive analysis of the Australia period care market is conducted by following key product positioning and monitoring the top competitors within the market framework.

Enquire More About this Report @https://www.alliedmarketresearch.com/purchase-enquiry/14685

𝐑𝐞𝐚𝐬𝐨𝐧𝐬 𝐭𝐨 𝐛𝐮𝐲 𝐀𝐮𝐬𝐭𝐫𝐚𝐥𝐢𝐚 𝐏𝐞𝐫𝐢𝐨𝐝 𝐂𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭:

• Mergers and acquisitions should be well-planned by identifying the best manufacturer.
• Sort new clients or possible partners into the demographic you’re looking for.
• Suitable for providing dependable and high-quality data and analysis to assist your internal and external presentations.
• Develop tactical initiatives by gaining a better grasp of the areas in which huge corporations can intervene.
• To increase and grow business potential and reach, develop and plan licencing and licencing strategies by finding possible partners with the most appealing projects.
• Recognize newcomers with potentially strong product portfolios and devise effective counter-strategies to acquire a competitive edge.
• To develop effective R&D strategies, gather information, analysis, and strategic insight from competitors.

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 "𝐀𝐌𝐑 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

○ Organic Tampons Market Will Show An Increase Of By 2027, Report
○ Period Panties Market to Witness a Pronounce Growth During 2020-2027

○ Organic Feminine Care Market Growth Opportunities In Global Industry By 2020-2027
https://www.alliedmarketresearch.com/organic-feminine-care-market-A07066

○ Tissue Paper Market Will Show An Increase Of By 2030, Report
https://www.alliedmarketresearch.com/tissue-paper-market-A16067

○ Sensitive Skin Wipes Market Opportunity, Estimations, and Analysis
https://www.alliedmarketresearch.com/sensitive-skin-wipes-market-A08034

○ Baby Wipes Market Size, Analysis, Opportunities, Business Outlook
https://www.alliedmarketresearch.com/baby-wipes-market

○ Hosiery Market Size, Growth Analysis, Opportunities, Business Outlook
https://www.alliedmarketresearch.com/hosiery-market

David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other